Insitro was founded in 2018 by Daphne Koller. The company has not publicly endorsed plans to participate in an IPO.

Insitro is an AI-powered drug development company. Board member Dr. Roger Perlmutter describes the three pillars of the company's approach as, "Target identification, lead discovery, and the elaboration of highly evolved therapeutic candidates." Insitro has raised more than $600 million in venture capital funding from investors including CPP Investments, Andreessen Horowitz, T. Rowe Price Associates, Casdin Capital, Temasek, and Softbank Investment Advisors. The company did not disclose valuation figures following a $400 million Series C fundraising round in 2021.

These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Register for Details

For more details on financing and valuation for Insitro, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Insitro

Forge green plus iconForge green minus icon

What is Insitro's IPO price?

The IPO price for Insitro will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Insitro?

Insitro is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Insitro shares pre-IPO?

If you own Insitro pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Insitro a publicly traded company?

Insitro is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Insitro's funding to date?

Insitro has raised $628.63MM to date.
Forge green plus iconForge green minus icon

When was Insitro founded?

Insitro was founded in 2018.

Who are Insitro's major investors?

Andreessen Horowitz
Arch Venture Partners
Two Sigma Ventures
HOF Capital
Third Rock Ventures
A&E Investments

Insitro funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$400MM raised $XXX.XX $XXX.XX

Series B

$149.22MM raised $XXX.XX $XXX.XX

Series A-1 and A-2

$79.41MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.